Seeing Is Believing
Currently out of the existing stock ratings of James Lee, 374 are a BUY (71.51%), 16 are a SELL (3.06%), 133 are a HOLD (25.43%).
Analyst James Lee, currently employed at MIZUHO, carries an average stock price target met ratio of 59.32% that have a potential upside of 38.35% achieved within 166 days.
James Lee’s has documented 1,045 price targets and ratings displayed on 47 stocks. The coverage is on Communication Services, Consumer Cyclical, Healthcare, Technology sectors.
Most recent stock forecast was given on AMZN, Amazon.com at 10-Dec-2024.
Analyst best performing recommendations are on CORT (CORCEPT THERAPEUTICS ORPORATED).
The best stock recommendation documented was for CORT (CORCEPT THERAPEUTICS ORPORATED) at 8/2/2023. The price target of $29 was fulfilled within 1 day with a profit of $3.99 (15.95%) receiving and performance score of 159.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$123
$-10.06 (-7.56%)
$140
16 days ago
(04-Dec-2024)
12/15 (80%)
$-14.34 (-10.44%)
119
Hold
$131
$-2.06 (-1.55%)
$145
1 months 2 days ago
(18-Nov-2024)
10/15 (66.67%)
$-1.05 (-0.80%)
110
Buy
$160
$26.94 (20.25%)
$130
1 months 9 days ago
(11-Nov-2024)
8/13 (61.54%)
$21.92 (15.87%)
176
Buy
$158
$24.94 (18.74%)
$167
1 months 9 days ago
(11-Nov-2024)
10/14 (71.43%)
$19.92 (14.43%)
196
Hold
$145
$11.94 (8.97%)
$125
1 months 12 days ago
(08-Nov-2024)
12/17 (70.59%)
$11.29 (8.44%)
37
Which stock is James Lee is most bullish on?
Which stock is James Lee is most reserved on?
What Year was the first public recommendation made by James Lee?